Try our Advanced Search for more refined results
Life Sciences - November, 2005
35 articles
- Acacia Takes Aim At Hospitals With New Patent Portfolio
- Preliminary Injunction Forces Medical Device Off Shelves
- Teva, Sandoz Launch At-Risk Versions of Pfizer Drug
- Suit Challenges USPTO Decision On Biotech Dispute
- Pfizer Wins Lipitor Patent Challenge
- China To Revamp Intellectual Property Laws: Report
- Ulcer Drug Patents Spark Court Battle
- Federal Circuit Upholds Injunction Vs. Teva, Ranbaxy
- Mylan Failed To Prove Identical Ingredients: Abbott Suit
- Robins Kaplan Hires Former Medtronic Legal Honcho
- DNA Replication Suit Favors Invitrogen In Federal Circuit
- J&J Faces New Challenge To Schizophrenia Drug
- Roche, Gilead Reach Tamiflu Agreement
- J&J-Guidant Merger Spotlights Stent Patent Wars
- Drug Store Giants Challenged Over Generic Packaging
- McDermott Snags NY IP Litigators From Morgan Lewis
- Sanofi-Aventis Must Allow News Site To Use Drug Name
- Tamoxifen Ruling Eases Hatch-Waxman Settlements
- Judge Bans Andrx, Ranbaxy Generic Versions Of Biaxin
- Impax Opens New Front In Adderall Battle With Shire
- Israel Revamps Drug Patent Extension Policy
- AstraZeneca Sues Teva Over Seroquel Patent Challenge
- Amgen Sues Roche Over Anemia Treatment
- FTC Lawsuit Sends Barr Back To Court
- Charges Mount Against Guidant As J&J Deal Sours
- In A Twist, Generics Maker Says Pfizer Infringed Patent
- Authorized Generics Deal Cleared Of Antitrust Charges
- Pfizer and Mylan Back To Court In Lengthy Dispute
- ImClone Stockholders Settle Insider Trading Charges
- IP Litigation Awards, Settlements Reach Record Highs
- Supreme Court May Co-Opt Patent Reform
- Drug Makers Gear Up For Round Two In Lipitor Case
- Chief Justice Drops Out Of Landmark Patent Case
- Supreme Court Mulls Case On Authorized Generics
- Novartis Purchase Of Chiron Puts Spotlight On Biologics